Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Brian Volkman
AddedFeb 17, 2024
UpdatedMay 31, 2026
Brian Volkman

Brian Volkman

Co-Founder, XLock Biosciences

CrunchbaseLinkedIn

Brian Volkman's Career

XLock Biosciences
XLock Biosciences

Milwaukee, WI, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Brian Volkman's Career

XLock Biosciences
XLock Biosciences
Angel$100k82022Milwaukee, WI, US
Co-Founder

Leadership at XLock Biosciences

Chad KoplinskiChad KoplinskiCo-Founder
William ClarkeWilliam ClarkeCEO
Michael DwinellMichael DwinellCo-Founder
Francis PetersonFrancis PetersonCo-Founder

Similar to XLock Biosciences

Cryptyx BioscienceCryptyx BiosciencePrinceton, NJ, USDrug Discoveryest. 2020Cryptyx BiosciencePrinceton, NJ, US · est. 2020

Cryptyx Bioscience: A biopharmaceutical platform unlocking therapeutic potential in bacteria.

Angel · $256k1
Xios TherapeuticsXios TherapeuticsBoston, MA, USTherapeuticsest. 2015Xios TherapeuticsBoston, MA, US · est. 2015

Xios Therapeutics: Innovating small molecule therapeutics for enhanced immuno-oncology treatments.

Pre-Seed · $7M30
Terremoto BiosciencesTerremoto BiosciencesSan Francisco, CA, USMedicine Developmentest. 2021Terremoto BiosciencesSan Francisco, CA, US · est. 2021

Terremoto Biosciences: Leveraging lysine-based biotech for optimized medicine development.

Series B · $250M41
X4 PharmaceuticalsX4 PharmaceuticalsBoston, MA, USTherapeuticsest. 2014X4 PharmaceuticalsBoston, MA, US · est. 2014

X4 Pharmaceuticals: A clinical-stage biopharmaceutical firm specializing in novel therapeutics for rare diseases and cancer.

Public · $542.9M72

Brian Volkman's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailKim Beom-sooKim Beom-sooCo-Founder · KakaoBrian KimBrian KimCo-Founder · KakaoJB LEEJB LEECo-Founder · Kakao

People Similar to Brian Volkman

Ashutosh SinghalAshutosh SinghalCo-Founder · BenchlingAndrew BensonAndrew BensonCo-Founder · Synbiotic HealthSam BockSam BockCo-Founder · Paragon VitaminsWilliam SandbornWilliam SandbornCo-Founder · Shoreline Biosciences